Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iparomlimab and Tuvonralimab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07286942
What this trial is testing

Stereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 Trial

Who this might be right for
NSCLCNSCLC (Non-small Cell Lung Cancer)
Jiangsu Cancer Institute & Hospital 24
Testing effectiveness (Phase 2)Looking for participantsNCT07267078
What this trial is testing

Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Peking Union Medical College Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT06942416
What this trial is testing

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Who this might be right for
Cervical CancerNeoplasm Recurrence, LocalOligometastatic
Shandong Cancer Hospital and Institute 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT07205497
What this trial is testing

QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced Cervical Cancer

Who this might be right for
Neoadjuvant ImmunotherapyLocally Advanced Cervical Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07348861
What this trial is testing

A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Zheng Min 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT07160647
What this trial is testing

The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)

Who this might be right for
dMMR/MSI-H-type Rectal Adenocarcinoma
Sir Run Run Shaw Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT07127822
What this trial is testing

Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer

Who this might be right for
Gastric / Gastroesophageal Junction AdenocarcinomaMSI-H Cancer
Peking University 106
Not applicableNot Yet RecruitingNCT07769853
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Chemotherapy and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)5-12cm to Anal Verge
Zhejiang University 56
Testing effectiveness (Phase 2)Looking for participantsNCT07841574
What this trial is testing

HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Lianghe Lu 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07833241
What this trial is testing

Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC

Who this might be right for
Borderline Resectable Pancreatic CancerHigh-Risk Resectable Pancreatic Cancer
Shanghai Zhongshan Hospital 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06751277
What this trial is testing

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Recurrent or Metastatic Endometrial Cancer
xiang yang 26
Testing effectiveness (Phase 2)Looking for participantsNCT07327788
What this trial is testing

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

Who this might be right for
Hepatecellular CarcinomaRALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and OxaliplatinBevacizumab+3 more
Nanfang Hospital, Southern Medical University 38
Testing effectiveness (Phase 2)Looking for participantsNCT06954116
What this trial is testing

Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Tongji Hospital 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083375
What this trial is testing

A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.

Who this might be right for
Extensive Small Cell Lung Cancer
Zhijie Wang 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07152769
What this trial is testing

Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
Fudan University 104
Testing effectiveness (Phase 2)Looking for participantsNCT07291401
What this trial is testing

Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

Who this might be right for
Rectal Cancer Patients
Zhongnan Hospital 108
Very early researchLooking for participantsNCT07343791
What this trial is testing

Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.

Who this might be right for
DC-CIK TreatmentRegorafenibColorectal Cancer+2 more
JIANG LONGWEI 14
Testing effectiveness (Phase 2)Looking for participantsNCT07396324
What this trial is testing

Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer

Who this might be right for
HR-positive/HER2-negative Breast Cancer
RenJi Hospital 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07045805
What this trial is testing

Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric Cancer

Who this might be right for
Gastric Cancer (GC)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 66
Testing effectiveness (Phase 2)Looking for participantsNCT07090317
What this trial is testing

Iparomlimab and Tuvonralimab in HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 30
Next Page